News

Home/ News & Events

NEW! ESID Complimentary Membership Grants

A 2-year free membership and a discounted fee for the biennial meeting will each be offered to 10 candidates that belong to lower/lower-middle income countries, according to the  World Bank classification. Evaluation criteria: -&...

Job Research Foundation Announces Third Round of Funding

$400,000 in Grants Available to Researchers Investigating Causes/Treatments of Rare Multisystem Immunodeficiency Disorder
Deadline October 16, 2020

ESID Juniors - Call for Country Representatives 2020-2024 is closed!

Dear ESID Junior members,
You are kindly invited to nominate yourselves in representation of your country. 

ESID Summer School 2020 postponed to 2021

The next ESID Summer School will take place in 2021. 

ESID Board Elections 2020-2024 - Call for Candidates is closed now!

Dear Friends & Colleagues,
We are pleased to invite you to actively participate in this year’s ESID Board elections, and in particular to consider nominating yourself for a board position.

COPID19. Worldwide survey of COVID-19 in PID patients

With the emergence of SARS-CoV-2 and the COVID-19 pandemic, there is an urgent need to understand the impact of infection on immunodeficient individuals. 

PID Survey update - COVID-19

The Survey summary on COVID-19 in PID patients can be viewed  here.

The COVID Human Genetic Effort

Dear Friends and Colleagues,
Please find here a study proposal on behalf of Jean-Laurent Casanova, Lab of Human Genetics of Infectious Diseases, The Rockefeller University & HHMI, New York - Necker Hospital for Sick Children & INSERM, Paris.

Joint statement on the current epidemics of new Coronavirus

Together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID we have worked on a joint statement to provide guidance in advising patients with primary immunodeficiency under our care in the current COVID-19 context.

SARS CoV2, COVID19 and PIDs - survey for clinicians

Dear colleagues, on behalf of the ESID Society we would like to ask for your input in this global initiative and to fill out the SARS CoV2, COVID19 and PIDs Survey for clinicians.